sulbactam-ETX2514
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for sulbactam-ETX2514, covering 2019-06-05 to 2023-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex [Phase 3]